Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SHANGHAI, December 18 /PRNewswire/ -- CBI China (http://www.cbichina.com), C1 Energy (http://www.c1energy.net/), Shanghai Petroleum Exchange Ltd, and Galaxy Merchandise Exchange (GEMEX) will hold a press briefing in Beijing to sign agreements covering future collaboration between the four companies.

Two collaboration agreements will be signed in the ceremony. The first will be a merger agreement between CBI China and C1 Energy.

SAN FRANCISCO and LONDON, December 18 /PRNewswire/ --

- Acquisitions include one fully leased property and one value-add redevelopment opportunity, bringing the European portfolio to over 1 million square feet

INCHEON, South Korea, December 18 /PRNewswire/ --

Celltrion, Inc., a leading Korean biopharmaceutical company, announces that it has received approval from the U.S. Food and Drug Administration (FDA) to serve as a contract manufacturer to produce ORENCIA(R) (abatacept), a novel biologic agent for the treatment of rheumatoid arthritis, developed by Bristol-Myers Squibb Company (NYSE: BMY). The Supplemental Biological License Application (sBLA) was submitted by Bristol-Myers Squibb Company to meet expected long-term demand for ORENCIA(R).

Celltrion is the largest biopharmaceutical manufacturing facility in the Asia-Pacific region, and the only Asian large-scale cell-culture contract manufacturing facility which has successfully obtained approval from the U.S. FDA.

ZUG, Switzerland, December 18 /PRNewswire/ -- Swiss Hawk AG is pleased to announce that its portfolio company Hollywood Entertainment Exchange Plc ("HEE") has been the subject of a reverse takeover transaction whereby HEE has acquired 99.5% of the shares in Motion Network TV SA and HEE has been renamed to Motion Network Holding Plc ("MNTV"). As a result of the transaction Swiss Hawk AG holds 40 million shares in MNTV.

URL: http://www.swisshawk.com

About Motion Network Holding Plc ("MNTV")

TEANECK, New Jersey, December 18 /PRNewswire/ --

- New Global, 3-Year Relationship Spans Cognizant's Full Suite of Services in IT, Infrastructure Management and Business Process Outsourcing Services

Cognizant (Nasdaq: CTSH), a leading provider of global IT and business process outsourcing services, announced today a multi-year, multi-million dollar engagement with Merck & Co. (NYSE: MRK), a global research-driven pharmaceutical company.

Cognizant will extend its existing relationship with Merck, dating back to 2005, to become a key technology partner and provide a full suite of services encompassing applications outsourcing, IT infrastructure management and business process outsourcing services.

LONDON, December 18 /PRNewswire/ -- Energy Equity Resources (EER), the London-based upstream oil and gas company, announces imminent drilling of a further appraisal well on the growing Aje Field, in offshore Nigerian waters. Aje-4 well is located in Oil Mining Lease (OML) 113, 24 kms from the coast in western Nigeria, on the Benin border. This is 64 kms from Lagos and close to the West Africa Pipeline - only 12 kms away.

The Aje field was discovered in 1996 and revealed oil and gas reservoirs, of Cretaceous age, in water depths of 100 to over 1,500 metres. A second and third well were later drilled there, in 1997 and 2005 respectively. All three wells have intersected hydrocarbons.